|
U.S. Genomics' core genomic mapping technologies are capable of identifying
and quantitating individual molecules of DNA, RNA and proteins in a complex
sample. Universal reagent sets are used, and no target amplification or culture
is required. DNA detection using these technologies provides genomic species
identification, while quantitation of RNAs and proteins can be used to track
expression, within a highly mutiplexable assay format.
U.S. Genomics
proprietary mapping technologies are currently being developed to address major
unmet needs in
|
